ey0020.1-13 | Pediatric Thyroid Cancer | ESPEYB20
CA Lebbink , TP Links , A Czarniecka , RP Dias , R Elisei , L Izatt , H Krude , K Lorenz , M Luster , K Newbold , A Piccardo , M Sobrinho-Simoes , T Takano , AS Paul van Trotsenburg , FA Verburg , HM van Santen
ey0018.3-10 | Congenital hypothyroidism | ESPEYB18
JC Naafs , JP Marchal , E Fliers , PH Verkerk , MAJ Luijten , A Boelen , ASP van Trotsenburg , N Zwaveling-Soonawala
ey0019.3-4 | Thyroid development | ESPEYB19
G Dom , P Dmitriev , MA Lambot , Vliet G Van , D Glinoer , F Libert , A Lefort , JE Dumont , C Maenhaut
ey0019.6-16 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments | ESPEYB19
Blok CJ de , CM Wiepjes , Velzen DM van , AS Staphorsius , NM Nota , LJ Gooren , BP Kreukels , Heijer M den
ey0019.9-3 | Metabolic risk in childhood cancer | ESPEYB19
S Welsch , K Sawadogo , B Brichard , Ville de Goyet M de , Damme A Van , C Boulanger , P Lysy
ey0019.14-11 | Risk and Outcome | ESPEYB19
Goedegebuure Wesley J. , Van der Steen Manouk , Smeets Carolina CJ , Kerkhof Gerthe F , Hokken-Koelega Anita CS
ey0017.6-20 | Transgender Medicine: Treatment and Cardiovascular Effects | ESPEYB17
M Klaver , R de Mutsert , M van der Loos , CM Wiepjes , JWR Twisk , M den Heijer , J Rotteveel , DT Klink
ey0017.9-12 | Childhood Cancer, Radiation Therapy and Thyroid Disease | ESPEYB17
J Hess , K Schafernak , D Newbern , T Vern-Gross , J Foote , D Van Tassel , R Jamshidi , A Walsh
ey0016.4-4 | Important for Clinical Practice | ESPEYB16
MJE Walenkamp , JML Robers , JM Wit , GRJ Zandwijken , HA van Duyvenvoorde , W Oostdijk , ACS Hokken-Koelega , SG Kant , M Losekoot
ey0015.4-4 | Important for clinical practice | ESPEYB15
IM Beune , FH Bloomfield , W Ganzevoort , ND Embleton , PJ Rozance , AG van Wassenaer-Leemhuis , K Wynia , SJ Gordijn